Clinical Trial: Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes

U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07317115) titled 'Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes' on Dec. 19, 2025.

Brief Summary: Compare use of the Magnet System in side-to-side duodeno-ileostomy (Surgery) with semaglutide (Medication).

Study Start Date: Jan., 2026

Study Type: INTERVENTIONAL

Condition: Obesity (Disorder) Obesity & Overweight Type 2 Diabetes (T2DM)

Intervention: DEVICE: Magnet System

Magnet System for side-to-side magnetic compression anastomosis in a duodeno-ileostomy bipartition

DRUG: Semaglutide

Semaglutide (up to 2.4mg subcutaneous (SQ) injection weekly or dose tolerated according to side effects); a glucag...